Spinal Muscular Atrophy.
Kolb SJ, Kissel JT.
Neurol Clin. 2015 Nov;33(4):831-46. doi: 10.1016/j.ncl.2015.07.004.
Spinal Muscular Atrophy.
Nicolau S, Waldrop MA, Connolly AM, Mendell JR.
Semin Pediatr Neurol. 2021 Apr;37:100878. doi: 10.1016/j.spen.2021.100878. Epub 2021 Feb 11.
Childhood spinal muscular atrophy.
Younger DS, Mendell JR.
Handb Clin Neurol. 2023;196:43-58. doi: 10.1016/B978-0-323-98817-9.00030-2.
Spinal muscular atrophy: diagnosis and management in a new therapeutic era.
Arnold WD, Kassar D, Kissel JT.
Muscle Nerve. 2015 Feb;51(2):157-67. doi: 10.1002/mus.24497. Epub 2014 Dec 16.
Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening-A Systematic Review.
Aragon-Gawinska K, Mouraux C, Dangouloff T, Servais L.
Genes (Basel). 2023 Jun 29;14(7):1377. doi: 10.3390/genes14071377.
Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies.
Angilletta I, Ferrante R, Giansante R, Lombardi L, Babore A, Dell'Elice A, Alessandrelli E, Notarangelo S, Ranaudo M, Palmarini C, De Laurenzi V, Stuppia L, Rossi C.
Int J Mol Sci. 2023 Oct 3;24(19):14873. doi: 10.3390/ijms241914873.
Newborn screening programs for spinal muscular atrophy worldwide in 2023.
Vrščaj E, Dangouloff T, Osredkar D, Servais L; SMA NBS World Study Group.
J Neuromuscul Dis. 2024 Nov;11(6):1180-1189. doi: 10.1177/22143602241288095.
Spinal Muscular Atrophy: A (Now) Treatable Neurodegenerative Disease.
Fay A.
Pediatr Clin North Am. 2023 Oct;70(5):963-977. doi: 10.1016/j.pcl.2023.06.002. Epub 2023 Jul 26.
Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care.
Schorling DC, Pechmann A, Kirschner J.
J Neuromuscul Dis. 2020;7(1):1-13. doi: 10.3233/JND-190424.
Spinal Muscular Atrophy: Current Medications and Re-purposed Drugs.
Basak S, Biswas N, Gill J, Ashili S.
Cell Mol Neurobiol. 2024 Nov 8;44(1):75. doi: 10.1007/s10571-024-01511-3.
